temozolomide has been researched along with Obesity in 1 studies
Obesity: A status with BODY WEIGHT that is grossly above the recommended standards, usually due to accumulation of excess FATS in the body. The standards may vary with age, sex, genetic or cultural background. In the BODY MASS INDEX, a BMI greater than 30.0 kg/m2 is considered obese, and a BMI greater than 40.0 kg/m2 is considered morbidly obese (MORBID OBESITY).
| Excerpt | Relevance | Reference |
|---|---|---|
| "Obesity was associated with shorter survival in patients with MGMT methylated glioblastoma (median OS 22." | 3.11 | Prognostic impact of obesity in newly-diagnosed glioblastoma: a secondary analysis of CeTeG/NOA-09 and GLARIUS. ( Borger, V; Goldbrunner, R; Güresir, E; Hau, P; Herrlinger, U; Krex, D; Pietsch, T; Potthoff, AL; Sabel, M; Schäfer, N; Schaub, C; Schlegel, U; Schneider, M; Seidel, C; Steinbach, JP; Tzaridis, T; Vatter, H; Weller, J; Zeyen, T, 2022) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Weller, J | 1 |
| Schäfer, N | 1 |
| Schaub, C | 1 |
| Potthoff, AL | 1 |
| Steinbach, JP | 1 |
| Schlegel, U | 1 |
| Sabel, M | 1 |
| Hau, P | 1 |
| Seidel, C | 1 |
| Krex, D | 1 |
| Goldbrunner, R | 1 |
| Pietsch, T | 1 |
| Tzaridis, T | 1 |
| Zeyen, T | 1 |
| Borger, V | 1 |
| Güresir, E | 1 |
| Vatter, H | 1 |
| Herrlinger, U | 1 |
| Schneider, M | 1 |
1 trial available for temozolomide and Obesity
| Article | Year |
|---|---|
Prognostic impact of obesity in newly-diagnosed glioblastoma: a secondary analysis of CeTeG/NOA-09 and GLARIUS.
Topics: Antineoplastic Agents, Alkylating; Brain Neoplasms; DNA Methylation; DNA Modification Methylases; DN | 2022 |